Acumen Pharmaceuticals

ABOS

Börsenwert 15,6 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 RA Capital Management Boston, Massachusetts	52,8 Mio. $	–	–	–
2	2 Deep Track Capital Greenwich, Connecticut	21,3 Mio. $	+1,16 Mio. $	+173.182	+5 %
3	3 Sands Capital Ventures Arlington, Virginia	18,5 Mio. $	–	–	–
4	4 Knollwood Investment Advisory Hunt Valley, Maryland	9,06 Mio. $	+11,3 Mio. $	+1.678.510	Neu
5	5 Laurion Capital Management New York	6,52 Mio. $	–	–	–
6	6 BlackRock New York	6,18 Mio. $	+199.297 $	+29.660	+3 %
7	7 Great Point Partners Greenwich, Connecticut	6,03 Mio. $	-560.526 $	-83.419	-7 %
8	8 Vanguard Group Malvern, Pennsylvania	3,87 Mio. $	+435.357 $	+64.791	+10 %
9	9 Millennium Management New York	3,6 Mio. $	+1,31 Mio. $	+195.224	+41 %
10	10 Driehaus Capital Management Chicago, Illinois	3,04 Mio. $	-50.799 $	-7.560	-1 %
11	11 Pathstone Family Office Englewood, New Jersey	2,86 Mio. $	+1,86 Mio. $	+277.060	+109 %
12	12 Commodore Capital New York	2,69 Mio. $	-4,04 Mio. $	-601.685	-55 %
13	13 Woodline Partners San Francisco, California	2,3 Mio. $	-40.222 $	-5.986	-1 %
14	14 Perceptive Advisors New York	1,88 Mio. $	-353.104 $	-52.550	-13 %
15	GPC 15 Guardian Point Capital Charlottesville, Virginia	1,62 Mio. $	-671.940 $	-100.000	-25 %
16	16 Silverarc Capital Management Boston, Massachusetts	1,59 Mio. $	-839.152 $	-124.885	-30 %
17	17 Ikarian Capital Dallas, Texas	1,38 Mio. $	-638.713 $	-95.055	-27 %
18	18 D.E. Shaw & Co New York	1,31 Mio. $	+518.731 $	+77.199	+47 %
19	19 Hudson Bay Capital Management Stamford, Connecticut	1,3 Mio. $	+1,61 Mio. $	+240.000	Neu
20	20 Geode Capital Management Boston, Massachusetts	900.000 $	+61.650 $	+9.175	+6 %
21	21 WMS Partners Towson, Maryland	530.825 $	-549.425 $	-81.767	-45 %
22	22 Susquehanna International Group Bala Cynwyd, Pennsylvania	483.629 $	+420.372 $	+62.561	+232 %
23	23 Two Sigma Investments New York	474.530 $	+590.474 $	+87.876	Neu
24	24 Bridgeway Capital Management Houston, Texas	451.440 $	–	–	–
25	25 Boothbay Fund Management New York	339.741 $	+2.251 $	+335	+0,5 %

Acumen Pharmaceuticals ABOS Börsenwert 15,6 Mio. $

Acumen Pharmaceuticals

ABOS

Börsenwert 15,6 Mio. $